Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study
Health status improvement after TTVI was most strongly associated with the degree of TR reduction, although there was minimal additional improvement for most patients beyond a 3-grade reduction in TR. These findings support the goal of achieving mild or less TR with TTVI, although patients with torrential TR at baseline may be well served if moderate TR can be achieved.
Authors
- John Spertus
- Changfu Wu
- S. Dunlay
- Danielle M. Olds (ORCID: https://orcid.org/0000-0003-0256-3889)
- Philip Jones
- Kensey Gosch
- Saibal Kar
- David J. Cohen
- Suzanne V. Arnold
Institutions
- United States Food and Drug Administration (US)
- Saint Luke's Health System (US)
- St. Francis Hospital (US)
- St. Francis Hospital (US)
- Mayo Clinic in Arizona (US)
- Los Robles Hospital & Medical Center (US)
- Saint Luke's Hospital (US)
- Cardiovascular Research Foundation (US)
- St. Francis Hospital (US)
Publication Details
- Journal
- Circulation
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1161/circulationaha.125.076542
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Edwards Lifesciences
- Boston Scientific Corporation
- National Heart, Lung, and Blood Institute